Massey University launches diagnostics company Ampersand Technologies
4th November 2021
Rapid diagnostic tests are revolutionising how the world manages disease outbreaks. At the forefront of these tests is Ampersand Technologies, a Massey University spin-out company launched in 2021 with co-investment from Massey Ventures and Matū.
Why New Zealand's kauri dieback disease might not be a new invader.
25 July 2021
A pathogen killing our iconic kauri has likely been quietly lurking in New Zealand for hundreds of years – a finding that's led some scientists to ponder new questions about precisely how humans have influenced the rapid rise of dieback disease.
(Article by Jamie Morton, NZ Herald)